Vir Biotechnology (VIR) EBITDA (2018 - 2026)
Vir Biotechnology (VIR) EBITDA from Sep 30, 2018 to Mar 31, 2026. The TTM Vir Biotechnology (VIR) EBITDA is -$460M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Vir Biotechnology (VIR) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -27.34% |
| 3 Years TTM | +13.72% |
| 5 Years TTM | +3.97% |
| All Time TTM | +24.33% |
Annual EBITDA change of Vir Biotechnology (VIR)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$129M | -72.31% |
| 2025 | -$468M | -18.33% |
| 2024 | -$573M | -13.87% |
| 2023 | -$665M | -179.16% |
| 2022 | $840M | +97.13% |
| 2021 | $426M | -245.61% |
| 2020 | -$293M | +67.49% |
| 2019 | -$175M | +49.21% |
| 2018 | -$117M | +44.10% |
| 2017 | -$81M | N/A |
Comparison Vir Biotechnology (VIR) five years EBITDA CAGR with competitors
Vir Biotechnology (VIR) five years EBITDA CAGR is 3.97%.